Literature DB >> 1595595

Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases.

D Daya1, L Nazerali, G L Frank.   

Abstract

The distinction of metastatic ovarian carcinoma from a primary malignant ovarian neoplasm is crucial to its subsequent management. The most common metastatic carcinoma that mimics primary ovarian carcinoma is that of large bowel origin. The clinical and pathologic features of 25 cases of intestinal adenocarcinoma metastatic to the ovaries were analyzed. The patients ranged in age from 47 to 80 years (average age, 60 years). Most patients had abdominal pain and a pelvic mass. In 56%, the ovarian tumors and the large bowel carcinomas were discovered synchronously; 44% were metachronous. Seventy-five percent of the tumors were unilateral. Gross examination revealed that all the ovarian tumors were solid and cystic with smooth outer surfaces. Most of the tumors showed hemorrhage and necrosis. Histologic examination showed that 13 cases had a predominantly endometrioid-like pattern, four cases were predominantly mucinous, and the rest demonstrated a mixed pattern. The presence of a garland pattern with cribriform areas and "dirty" necrosis were the most distinctive features that were helpful in correctly differentiating these tumors from primary endometrioid ovarian carcinoma, with which they are often confused. Immunohistochemical stains for carcinoembryonic antigen showed strong intracytoplasmic positive staining in all the cases of intestinal adenocarcinoma metastatic to the ovaries, in contrast to primary ovarian endometrioid carcinoma, which stain negatively for carcinoembryonic antigen or show only intraluminal or apical positivity. As expected, intestinal adenocarcinoma metastatic to the ovaries had a very poor prognosis. Seventy percent of the patients died within a period of 1 to 19 months (average, 8.2 months). Its distinction from primary ovarian carcinoma is crucial because the management and prognosis of metastatic ovarian carcinoma of large intestine origin is different.

Entities:  

Mesh:

Year:  1992        PMID: 1595595     DOI: 10.1093/ajcp/97.6.751

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Metastatic ovarian tumor.

Authors:  Sarita Asotra; Jaishree Sharma; Neelam Sharma
Journal:  J Cytol       Date:  2009-10       Impact factor: 1.000

2.  Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.

Authors:  Richard J Zaino; Mark F Brady; Subodh M Lele; Helen Michael; Benjamin Greer; Michael A Bookman
Journal:  Cancer       Date:  2010-09-22       Impact factor: 6.860

3.  Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Authors:  Gozde Kir; Ayse Gurbuz; Ates Karateke; Mustafa Kir
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 4.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

5.  Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.

Authors:  J H Lagendijk; H Mullink; P J van Diest; G A Meijer; C J Meijer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

6.  Secondary Involvement of the Adnexa and Uterine Corpus by Carcinomas of the Uterine Cervix: A Detailed Morphologic Description.

Authors:  Carolina Reyes; Rajmohan Murali; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2015-11       Impact factor: 2.762

7.  The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.

Authors:  Mi Jin Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

8.  A case of Krukenberg carcinoma metastasized from colon cancer resembling mucinous cystadenocarcinoma of the ovary.

Authors:  Saori Shiono; Tsuyoshi Saito; Hiroaki Fujii; Atsushi Arakawa; Takanori Nakamura; Takashi Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.

Authors:  Anne Marszalek; Séverine Alran; Suzy Scholl; Virginie Fourchotte; Corinne Plancher; Christophe Rosty; Jean Philippe Meyniel; Vincent De Margerie; Thierry Dorval; Anne De La Rochefordière; Paul Cottu; Peter Petrow; Xavier Sastre-Garrau; Rémy Jacques Salmon
Journal:  Int J Surg Oncol       Date:  2010-07-25

10.  Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa.

Authors:  Bharat Rekhi; Sophia George; Bhulaxmi Madur; R F Chinoy; Rajesh Dikshit; Amita Maheshwari
Journal:  Diagn Pathol       Date:  2008-09-18       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.